Thermosensitive liposomes containing cisplatin functionalized by hyaluronic acid: preparation and physicochemical characterization
Source abstract
Abstract
This study aimed to develop a thermosensitive liposomal formulation (TSL) functionalized with hyaluronic acid (HA), to encapsulate a hydrophilic drug, the cisplatin (CDDP). The physicochemical and thermal characteristics of this new formulation were studied by dynamic light scattering (DLS), microcalorimetry, and small-angle X-ray scattering (SAXS) techniques. Our results showed mean diameter and PDI data characteristics of homogeneous formulations, indicating the absence of aggregation of vesicles after functionalization with HA. The efficiency of coating in the liposome surface was attributed to zeta potential values close to neutrality. DLS data showed a significant reduction in the average diameter and Kcps of the formulations evaluated at 40 °C. It was also observed that the HA-coating did not alter the Tm of the formulations. The SAXS profile of all formulations was characteristic of a lamellar organization regardless of temperature evaluated and showed dilation of the bilayer, caused by local misorientation in the structure of the lipids, confirming the conformational alteration due to warming. Therefore, the in vitro release profile showed that possible drug adsorption in the phospholipid bilayer may be generating the diffusion rate of CDDP before reaching Tm (42 °C), for TSL-CDDP and TSL-CDDP-SA-HA. For TSL-CDDP-HA, the presence of the polymer may be modulating this diffusion, generating a more controlled and slow release profile.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Ahmed K, Zaidi SF (2013) Treating cancer with heat: hyperthermia as promising strategy to enhance apoptosis. J Pakistan Med Assoc 63:504–508
2. Alavizadeh SH, Gheybi F, Nikpoor AR et al (2017) Therapeutic e ffi cacy of cisplatin thermosensitive liposomes upon mild hyperthermia in C26 tumor bearing BALB / c mice. Am Chem Soc 14:712–721. https://doi.org/10.1021/acs.molpharmaceut.6b0100610.1021/acs.molpharmaceut.6b01006 ↗
3. Almalik A, Karimi S, Ouasti S et al (2013) Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles. Biomaterials 34:5369–5380. https://doi.org/10.1016/j.biomaterials.2013.03.06510.1016/j.biomaterials.2013.03.065 ↗
4. Arpicco S, Lerda C, Dalla Pozza E et al (2013) Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm 85:373–380. https://doi.org/10.1016/j.ejpb.2013.06.00310.1016/j.ejpb.2013.06.003 ↗
5. Behrouzkia Z, Joveini Z, Keshavarzi B et al (2016) Hyperthermia: how can it be used? Oman Med J 31:89–97. https://doi.org/10.5001/omj.2016.1910.5001/omj.2016.19 ↗
6. Biltonen RL, Lichtenberg D (1993) The use of differential scanning calorimetry as a tool to characterize liposome preparations. Chem Phys Lipids 64:129–142. https://doi.org/10.1016/0009-3084(93)90062-810.1016/0009-3084(93)90062-8 ↗
7. Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9:1–33. https://doi.org/10.3390/pharmaceutics902001210.3390/pharmaceutics9020012 ↗
8. Chatterjee DK, Diagaradjane P, Krishnan S (2011) Nanoparticle-mediated hyperthermia in cancer therapy. Ther Deliv 2:1001–1014. https://doi.org/10.4155/tde.11.7210.4155/tde.11.72 ↗
9. Chen C-y, Kim TH, Wu W-c; Huang C-m; Wei, Hua, (2013) Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC. Drug Dev Ind Pharm 39:197–204. https://doi.org/10.3109/03639045.2012.66891210.3109/03639045.2012.668912 ↗
10. Dabbagh N, Soroosh A, Khorgami Z et al (2015) Single-incision laparoscopic cholecystectomy versus mini-laparoscopic cholecystectomy: A randomized clinical trial study. J Res Med Scihttps://doi.org/10.4103/1735-1995.17298210.4103/1735-1995.172982 ↗
11. da Silva Tinoco LM, da Silva FLO, Ferreira LAM et al (2018) Hyaluronic acid-coated nanoemulsions loaded with a hydrophobic ion pair of all-trans retinoic acid for improving the anticancer activity. Braz J Pharm Sci 54:1–10. https://doi.org/10.1590/s2175-9790201800041736110.1590/s2175-97902018000417361 ↗
12. Dos Santos Giuberti C, De Oliveira Reis EC, Ribeiro Rocha TG et al (2011) Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin. J Liposome Res 21:60–69. https://doi.org/10.3109/0898210100375437710.3109/08982101003754377 ↗
13. De Oliveira MC, Fattal E, Couvreur P, Lesieur P, Bourgaux C, Ollivon M, Dubernet C (1998) pHsensitive liposomes as a carrier for oligonucleotides: A physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in quasi-anhydrous samples. Biochim Biophys Acta - Biomembr 1372:301–310. https://doi.org/10.1016/S0005-2736(98)00067-410.1016/S0005-2736(98)00067-4 ↗
14. De Oliveira MC, Rosilio V, Lesieur P, Bourgaux C, Couvreur P, Ollivon M, Dubernet C (2000) pHsensitive liposomes as a carrier for oligonucleotides: A physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water. Biophys Chem 87:127–37. https://doi.org/10.1016/S0301-4622(00)00180-010.1016/S0301-4622(00)00180-0 ↗
15. Dufaÿ Wojcicki A, Hillaireau H, Nascimento TL et al (2012) Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor. J Control Releasehttps://doi.org/10.1016/j.jconrel.2012.07.01510.1016/j.jconrel.2012.07.015 ↗
16. El Kechai N, Geiger S, Fallacara A et al (2017) Mixtures of hyaluronic acid and liposomes for drug delivery: phase behavior, microstructure and mobility of liposomes. Int J Pharm 523:246–259. https://doi.org/10.1016/j.ijpharm.2017.03.02910.1016/j.ijpharm.2017.03.029 ↗
17. Gasperini AAM, Puentes-martinez XE, Balbino TA et al (2015) Association between cationic liposomes and low molecular weight hyaluronic acid. Am Chem Soc 3308(31):3308–3317. https://doi.org/10.1021/la504586510.1021/la5045865 ↗
18. Gomes IP, Duarte JA, Maia ALC et al (2019) Thermosensitive nanosystems associated with hyperthermia for cancer treatment. Pharmaceuticals 12https://doi.org/10.3390/ph1204017110.3390/ph12040171 ↗
19. Hornof M, Urtti A (2008) Low molecular weight hyaluronan shielding of DNA / PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells. J Gene Med 10:70–80. https://doi.org/10.1002/jgm.112510.1002/jgm.1125 ↗
20. Jiang T, Mo R, Bellotti A et al (2014) Gel-liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy. Adv Funct Mater 24:2295–2304. https://doi.org/10.1002/adfm.20130322210.1002/adfm.201303222 ↗
21. Jung M (2000) Polymerisation in Bilayers, 1st ed. Ludwigshafen - Alemanha
22. Júnior ÁDC, Mota LG, Nunan EA et al (2007) Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice. Life Scihttps://doi.org/10.1016/j.lfs.2006.10.01110.1016/j.lfs.2006.10.011 ↗
23. Kim KY (2007) Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomed Nanotechnol Biol Med 3:103–110. https://doi.org/10.1016/j.nano.2006.12.00210.1016/j.nano.2006.12.002 ↗
24. Kuo JW (2005) Practical aspects of hyaluronan based medical products, 1st edn. Taylor and Francis, Boca Raton -Flórida10.1201/9781420037647 ↗
25. Leite EA, Souza CM, Carvalho-Júnior ÁD et al (2012) Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity. Int J Nanomedicine 7:5259–5269. https://doi.org/10.2147/IJN.S3465210.2147/IJN.S34652 ↗
26. Lokerse WJM, Bolkestein M, Dalm SU et al (2017) Comparing the therapeutic potential of thermosensitive liposomes and hyperthermia in two distinct subtypes of breast cancer. J Control Releasehttps://doi.org/10.1016/j.jconrel.2017.05.00510.1016/j.jconrel.2017.05.005 ↗
27. Lv Y, Xu C, Zhao X et al (2018) Nanoplatform assembled from a CD44-targeted prodrug and smart liposomes for dual targeting of tumor microenvironment and cancer cells. ACS Nanohttps://doi.org/10.1021/acsnano.7b0805110.1021/acsnano.7b08051 ↗
28. Mattheolabakis G, Nie T, Constantinides PP, Rigas B (2012) Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation. Pharm Res 29:1435–1443. https://doi.org/10.1007/s11095-011-0619-y10.1007/s11095-011-0619-y ↗
29. May JP, Li S (2013) Hyperthermia-induced drug targeting. Expert Opin Drug Deliv 10:511–527. https://doi.org/10.1517/17425247.2013.75863110.1517/17425247.2013.758631 ↗
30. Monteiro LOF, Malachias Â, Pound-Lana G et al (2018) Paclitaxel-loaded pH-sensitive liposome: new insights on structural and physicochemical characterization. Langmuir 34:5728–5737. https://doi.org/10.1021/acs.langmuir.8b0041110.1021/acs.langmuir.8b00411 ↗
31. Neunert G, Tomaszewska-Gras J, Siejak P et al (2018) Disruptive effect of tocopherol oxalate on DPPC liposome structure: DSC, SAXS, and fluorescence anisotropy studies. Chem Phys Lipids 216:104–113. https://doi.org/10.1016/j.chemphyslip.2018.10.00110.1016/j.chemphyslip.2018.10.001 ↗
32. New RRC (1990) Introduction In: Liposomes a practical approach., 1st ed. New York10.1093/oso/9780199630882.003.0001 ↗
33. Papahadjopoulos D, Jacobson K, Nir S, Isac I (1973) Phase transitions in phospholipid vesicles Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. BBA -Biomembr 311:330–348. https://doi.org/10.1016/0005-2736(73)90314-310.1016/0005-2736(73)90314-3 ↗
34. Pavia D, Lampman G, Kriz G, Vyvyan J (2010) Introdução à Espectroscopia, 1st ed. Washington - EUA
35. Peller M, Willerding L, Limmer S et al (2016) Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors. J Control Release 237:138–146. https://doi.org/10.1016/j.jconrel.2016.06.03510.1016/j.jconrel.2016.06.035 ↗
36. Qhattal HSS, Hye T, Alali A, Liu X (2014) Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano 8:5423–5440. https://doi.org/10.1021/nn405839n10.1021/nn405839n ↗
37. Ta T, Porter TM (2013) Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release 169:112–125. https://doi.org/10.1016/j.jconrel.2013.03.03610.1016/j.jconrel.2013.03.036 ↗
38. Tezcan S, Özdemir F, Turhal S, Izzettin FV (2013) High performance liquid chromatographic determination of free cisplatin in different cancer types. Der Pharma Chem 5:169–174
39. Torchilin VP (2014) Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature Reviews Drug Discovery. 13:813–827. https://doi.org/10.1038/nrd433310.1038/nrd4333 ↗
40. Toro-Córdova A, Ledezma-Gallegos F, Mondragon-Fuentes L et al (2016) Determination of liposomal cisplatin by high-performance liquid chromatography and its application in pharmacokinetic studies. J Chromatogr Sci 54:1016–1021. https://doi.org/10.1093/chromsci/bmw03910.1093/chromsci/bmw039 ↗
41. Toriyabe N, Hayashi Y, Hyodo M, Harashima H (2011) Synthesis and evaluation of stearylated hyaluronic acid for the active delivery of liposomes to liver endothelial cells. Biol Pharm Bull 34:1084–1089. https://doi.org/10.1248/bpb.34.108410.1248/bpb.34.1084 ↗
42. Yatvin M, Weinstein J, Dennis W, Blumenthal R (1978) Design of liposomes for enhanced local release of drugs by hyperthermia. Science 80(202):1290–1293. https://doi.org/10.1126/science.36465210.1126/science.364652 ↗
43. Sheridan C, Kishimoto H, Fuchs RK et al (2006) CD44+/CD24-breast cancer cells exhibit enhanced invase properties: an early step necessary for metastasis. Breast Cancer Res 8:1–13. https://doi.org/10.1186/bcr161010.1186/bcr1610 ↗
44. Ravar F, Saadat E, Gholami M et al (2016) Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release 229:10–22. https://doi.org/10.1016/j.jconrel.2016.03.01210.1016/j.jconrel.2016.03.012 ↗
45. Ruano L, Cardenas G, Nogueira JJ (2020) Electrostatic Interactions with choline and phosphate groups regulate cisplatin permeation through a dioleoylphosphocholine bilayer. ChemRxiv. https://doi.org/10.26434/chemrxiv.12917957.v110.26434/chemrxiv.12917957.v1 ↗
46. Silva SML, Coelho LN, Malachias A, Perez CA, Pesquero JL, Magalhães-Paniago R, De Oliveira MC (2011) Study of the structural organization of cyclodextrin-DNA complex loaded anionic and pH-sensitive liposomes. Chem Phys Lett 506:66–70. https://doi.org/10.1016/j.cplett.2011.02.05010.1016/j.cplett.2011.02.050 ↗
47. Vaupel P (2004) Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14:198–206. https://doi.org/10.1016/j.semradonc.2004.04.00810.1016/j.semradonc.2004.04.008 ↗
48. Vaupel P, Rallinoâ F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment human tumors : a review. Cancer Res 49:6449–6465. https://doi.org/10.1016/S0360-3016(99)00362-410.1016/S0360-3016(99)00362-4 ↗
49. White SC, Lorigan P, Margison GP et al (2006) Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer. Br J Cancer 95:822–828. https://doi.org/10.1038/sj.bjc.660334510.1038/sj.bjc.6603345 ↗
50. Willerding L, Limmer S, Hossann M et al (2016) Method of hyperthermia and tumor size in fl uence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors. J Control Release 222:47–55. https://doi.org/10.1016/j.jconrel.2015.12.00410.1016/j.jconrel.2015.12.004 ↗
51. Wust P, Hildebrandt B, Sreenivasa G et al (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3:487–497. https://doi.org/10.1016/S1470-2045(02)00818-510.1016/S1470-2045(02)00818-5 ↗